149 related articles for article (PubMed ID: 6298581)
1. Comparison of biological activities of Bordetella pertussis mutants lacking the ability to produce filamentous hemagglutinin with similar activities of other smooth strains.
Watanabe M; Munoz JJ
Microbiol Immunol; 1982; 26(10):965-9. PubMed ID: 6298581
[No Abstract] [Full Text] [Related]
2. Mutant of Bordetella pertussis which lacks ability to produce filamentous hemagglutinin.
Watanabe M; Nakase Y
Infect Immun; 1982 Mar; 35(3):1018-23. PubMed ID: 6279510
[TBL] [Abstract][Full Text] [Related]
3. Protective activities of "Bordetella pertussis" Tn5 mutants in mice.
Olander RM; Muotiala A; Parviainen T; Runeberg-Nyman K
Ann Sclavo Collana Monogr; 1986; 3(1-2):329-35. PubMed ID: 2892513
[No Abstract] [Full Text] [Related]
4. Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis.
Weiss AA; Hewlett EL; Myers GA; Falkow S
J Infect Dis; 1984 Aug; 150(2):219-22. PubMed ID: 6088647
[TBL] [Abstract][Full Text] [Related]
5. Antigens in whooping cough vaccine and antibody levels induced by vaccination of children.
Ashworth LA; Robinson A; Irons LI; Morgan CP; Isaacs D
Lancet; 1983 Oct; 2(8355):878-81. PubMed ID: 6137697
[TBL] [Abstract][Full Text] [Related]
6. Synergistic effect of Bordetella pertussis lymphocytosis-promoting factor on protective activities of isolated Bordetella antigens in mice.
Robinson A; Irons LI
Infect Immun; 1983 May; 40(2):523-8. PubMed ID: 6301999
[TBL] [Abstract][Full Text] [Related]
7. Characterization of two adhesins of Bordetella pertussis for human ciliated respiratory-epithelial cells.
Tuomanen E; Weiss A
J Infect Dis; 1985 Jul; 152(1):118-25. PubMed ID: 2861240
[TBL] [Abstract][Full Text] [Related]
8. Binding of murine antibodies against whole-cell pertussis vaccine or filamentous haemagglutinin by Bordetella pertussis from patients with whooping cough.
van den Berg BM; Beekhuizen H; Van Furth R; Mooi FR
Scand J Immunol; 2000 May; 51(5):530-2. PubMed ID: 10792847
[TBL] [Abstract][Full Text] [Related]
9. The cellular immune response to Bordetella pertussis in two children with whooping cough.
Hafler JP; Pohl-Koppe A
Eur J Med Res; 1998 Nov; 3(11):523-6. PubMed ID: 9810032
[TBL] [Abstract][Full Text] [Related]
10. Biological activities of pertussigen from Bordetella pertussis strains of various agglutinogen types.
Watanabe M
Microbiol Immunol; 1984; 28(5):509-15. PubMed ID: 6088952
[TBL] [Abstract][Full Text] [Related]
11. [Pathogenetic significance of Bordetella pertussis toxin].
Finger H
Immun Infekt; 1985 Apr; 13(2):47-9. PubMed ID: 2860059
[No Abstract] [Full Text] [Related]
12. Characterization of murine lung inflammation after infection with parental Bordetella pertussis and mutants deficient in adhesins or toxins.
Khelef N; Bachelet CM; Vargaftig BB; Guiso N
Infect Immun; 1994 Jul; 62(7):2893-900. PubMed ID: 7999145
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the protective effects of the pertussis acellular vaccine with the component vaccine, which have different amounts of fimbriae, against the experimental aerosol infection of mice with Bordetella pertussis.
Morokuma K; Ginnaga A; Nishihara T; Tsunoda S; Furukawa M; Aihara K; Sakoh M
Dev Biol Stand; 1991; 73():223-32. PubMed ID: 1685713
[TBL] [Abstract][Full Text] [Related]
14. [Immunobiologic activity of Bordetella pertussis strains defective in various virulence factors].
Smirnov VD; Chuprinina RP; Siundiukova RA; Maksiutov RV
Zh Mikrobiol Epidemiol Immunobiol; 1989 Mar; (3):8-10. PubMed ID: 2545060
[TBL] [Abstract][Full Text] [Related]
15. Molecular aspects of Bordetella pertussis pathogenesis.
Locht C
Int Microbiol; 1999 Sep; 2(3):137-44. PubMed ID: 10943406
[TBL] [Abstract][Full Text] [Related]
16. Evolution of whooping cough bacterium may reduce vaccine effectiveness.
Riedmann EM
Hum Vaccin Immunother; 2014; 10(6):1430. PubMed ID: 25396233
[No Abstract] [Full Text] [Related]
17. Effect of hydromechanical stress on cellular antigens of Bordetella pertussis.
Rodriguez ME; Hozbor DF; Yantorno OM
J Ind Microbiol; 1996 Jul; 17(1):53-5. PubMed ID: 8987690
[TBL] [Abstract][Full Text] [Related]
18. Investigating pertussis toxin and its impact on vaccination.
Coutte L; Locht C
Future Microbiol; 2015; 10(2):241-54. PubMed ID: 25689536
[TBL] [Abstract][Full Text] [Related]
19. Protective activities of the filamentous hemagglutinin and the lymphocytosis-promoting factor of Bordetella pertussis in mice.
Oda M; Cowell JL; Burstyn DG; Manclark CR
J Infect Dis; 1984 Dec; 150(6):823-33. PubMed ID: 6094673
[TBL] [Abstract][Full Text] [Related]
20. An antigen-conserving ELISA for detecting human antibodies to Bordetella pertussis filamentous hemagglutinin.
Vernon SK; Wiener FP; Urbano C; Levner MH
J Biol Stand; 1986 Apr; 14(2):157-61. PubMed ID: 2876000
[No Abstract] [Full Text] [Related]
[Next] [New Search]
